Maguinsalog, Ethyl .
HRN: 29-01-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2026
CEFUROXIME 1.5GM (VIAL)
06/27/2026
07/04/2026
IV
1.5 Grams
Q8
UTI; Systemic Viral Illness
Checking Initial Appropriateness
06/28/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/28/2026
07/05/2026
IV
600mg TIV X Q Hour Infusion
Q8h
Cellulitis
Checking Initial Appropriateness
07/05/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/06/2026
07/08/2026
IV
300mg
Q8
Cellulitis
Checking Initial Appropriateness
07/08/2026
CLINDAMYCIN 300MG (CAP)
07/08/2026
07/13/2026
PO
1 Tab
BID
Cellulitis
Checking Initial Appropriateness